JONES STEVEN C 4
4 · NEOGENOMICS INC · Filed Sep 30, 2020
Insider Transaction Report
Form 4
JONES STEVEN C
DirectorExecutive VP of Finance10% Owner
Transactions
- Sale
Common Stock
2020-09-28$36.34/sh−38,951$1,415,479→ 1,341,049 total(indirect: By Aspen Select Opportunity Fund) - Sale
Common Stock
2020-09-28$36.56/sh−19,000$694,640→ 178,932 total - Sale
Common Stock
2020-09-29$36.95/sh−141,049$5,211,761→ 1,200,000 total(indirect: By Aspen Select Opportunity Fund) - Sale
Common Stock
2020-09-29$36.55/sh−81,000$2,960,550→ 97,932 total - Gift
Common Stock
2020-09-29−25,000→ 72,932 total
Holdings
- 125,000(indirect: By Trust)
Common Stock
- 100,000(indirect: By Aspen Select Opportunity Fund)
Stock Option (Right to Buy)
Exercise: $7.15Exp: 2021-04-20→ Common Stock (100,000 underlying) - 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 30,476(indirect: By Jones Network, LP)
Common Stock
- 10,000
Stock Option (Right to Buy)
Exercise: $7.27Exp: 2022-05-25→ Common Stock (10,000 underlying) - 40,757(indirect: By Trust)
Common Stock
- 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (3)
- [F1]Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
- [F2]On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
- [F3]On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.